A preparation method of a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex with improved thermal stability and ferrous ion chelating capacity and application thereof

CN122954167APending Publication Date: 2026-10-23NANJING UNIV OF FINANCE & ECONOMICS
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202611174533.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-04
Publication Date
2026-10-23

AI Technical Summary

Technical Problem

[0007]本发明的目的在于提供一种乳铁蛋白-根皮苷-羧甲基纤维素三元复合物的制备方法及其应用,解决现有技术中乳铁蛋白热稳定性差、亚铁离子螯合能力衰减快、三元复合结构可控性低的技术问题

Benefits of technology

本发明构建的三元复合体系中的致密网络结构可以有效减少加热过程中活性成分的损耗,还一定程度上提升了亚铁离子螯合能力以及抗氧化能力。本发明构建的LF-Phl-CMC三元复合物适配实际食品加工中的热处理环节的同时保障了乳铁蛋白在加工后的功能活性,且整个制备过程不使用化学交联剂,仅通过非共价相互作用构建三元复合物,反应条件温和,最大程度保留了乳铁蛋白的天然构象与活性位点,产品安全性高,适合大规模工业化生产,具有广阔的应用前景:

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122954167A_ABST
    Figure CN122954167A_ABST
Patent Text Reader

Abstract

The application discloses a preparation method of a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex with improved thermal stability and ferrous ion chelating capacity and application thereof, and belongs to the field of food biological macromolecule modification and functional composite materials.The lactoferrin-phlorizin-carboxymethyl cellulose ternary complex constructed by the application can adapt to the heat treatment process in actual food processing, and can maintain the functional activity of lactoferrin after processing.The preparation system does not introduce a chemical crosslinking agent throughout the whole process, and only relies on non-covalent interaction to construct the ternary complex, the reaction condition is mild, the natural conformation and active site of lactoferrin can be retained to the maximum extent, the obtained product is high in safety, is suitable for large-scale industrial production, and has wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to a method for preparing a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex with improved thermal stability and ferrous ion chelating ability, and its application, belonging to the field of food biomacromolecule modification and functional composite materials. Background Technology

[0002] Lactoferrin (LF) is a globular iron-binding glycoprotein derived from milk and other mammalian body fluids. Its isoelectric point is pH 8.9, and it carries a positive charge under neutral to weakly alkaline conditions. Due to its broad-spectrum antibacterial, immunomodulatory, iron absorption-promoting, and antioxidant activities, LF is widely used as a core ingredient in functional foods and nutritional supplements. However, the heat denaturation temperature of LF is typically between 70°C and 75°C. During actual processing and in vivo digestion, heat-induced denaturation and aggregation lead to structural unfolding and masking of active sites, significantly weakening LF's iron-binding capacity, antioxidant activity, and emulsifying properties. These drawbacks significantly limit the direct application of LF in liquid dairy products, dairy beverages, and heat-sterilized functional foods.

[0003] To improve the processing stability of lactoferrin (LF), researchers attempted to introduce food-grade excipients such as polysaccharides or polyphenols to construct a composite system. Carboxymethyl cellulose (CMC), an anionic polysaccharide, is widely used as a carrier, emulsifier, and stabilizer in food and pharmaceuticals. The high viscosity and anionic properties of CMC may indicate that it can form an electrostatic complex with positively charged lactoferrin, inhibiting the thermal aggregation of LF through steric hindrance and electrostatic repulsion. However, the single electrostatic interaction is easily dissociated under thermal stress and cannot provide sufficient conformational protection. Even after heat treatment, the composite system still exhibited problems such as increased particle size and turbidity.

[0004] Meanwhile, the non-covalent complexation of polyphenols and lactoferrin (LF) has become a research hotspot in recent years. The introduction of polyphenols can, to some extent, protect the secondary structure of LF and delay thermally induced aggregation. Existing technologies mostly focus on binary systems of LF-polyphenols or LF-polysaccharides. However, binary complex systems still struggle to balance conformational stability and colloidal dispersion stability during heat treatment, resulting in limited improvements in functional activity. For example, patent application CN119453497A indicates that forming a complex with lactoferrin and chlorogenic acid or epicatechin can significantly improve the activity and structural stability of lactoferrin, but it still fails to fully address the conformational retention problem during heat treatment.

[0005] In recent years, some studies have begun to attempt to construct LF-polysaccharide-polyphenol ternary complex systems. For example, patent application CN118402591A uses lactoferrin, pectin, and gallic acid, chlorogenic acid, or rosmarinic acid as raw materials to construct a ternary complex and applies it to functional beverages. However, this technology mainly addresses the turbidity, precipitation, and stratification problems caused by the interaction of proteins, polysaccharides, and phenolic acids in beverage systems, aiming to improve the colloidal stability and sensory quality of beverages, without focusing on protecting the conformational stability of lactoferrin and maintaining its functional activity during thermal processing. Patent application CN108719999A further discloses a method for preparing a protein-polyphenol-polysaccharide covalent complex, which activates the carboxyl groups of polyphenols through the carbodiimide method to form covalent links with polysaccharides, and then uses laccase to induce covalent cross-linking between proteins and polysaccharide-polyphenol covalent complexes, thereby constructing a ternary covalent complex. While this technology can stably link lactoferrin, polyphenols, and polysaccharides with covalent bonds, resulting in complexes with certain thermal stability and antioxidant capacity, covalent modification inevitably involves chemical cross-linking agents (such as carbodiimide) and enzyme-catalyzed reactions. The reaction conditions are relatively harsh, which may cause irreversible effects on the native conformation of lactoferrin. Furthermore, the randomness of the covalent linkage sites may lead to the masking of active sites.

[0006] Therefore, how to combine the characteristics of polyphenols and polysaccharides, construct a ternary composite system through a suitable composite process, and utilize the multiple interactions among the three to achieve stable protection of lactoferrin conformation and further enhance its iron-binding capacity is a direction that urgently needs to be promoted in the current research on lactoferrin modification. Summary of the Invention

[0007] The purpose of this invention is to provide a method for preparing a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex and its application, thereby solving the technical problems of poor thermal stability of lactoferrin, rapid decay of ferrous ion chelating ability, and low controllability of ternary complex structure in the prior art.

[0008] This invention addresses the question of how multi-component non-covalent interactions synergistically enhance the structure and functional activity of lactoferrin. It utilizes a non-covalent complex of phlorizin and lactoferrin, further introducing a polysaccharide (carboxymethyl cellulose) to construct a ternary complex system. This not only effectively compensates for the instability of single lactoferrin during processing and digestion but also comprehensively improves its physicochemical properties and biological activity through the synergistic interaction mechanism among multiple components. This provides a safe and efficient new strategy for overcoming the application bottlenecks of lactoferrin and developing high-value-added functional dairy products.

[0009] The first objective of this invention is to provide a method for preparing a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex, the method comprising the following steps: (1) After mixing lactoferrin solution and phlorizin solution, a lactoferrin-phlorizin binary complex solution was prepared by dialysis; (2) The lactoferrin-phlorizin binary complex solution from step (1) is mixed with carboxymethyl cellulose solution at a volume ratio of 5:1 to 15:1 and stirred for 1 to 5 h to obtain a mixed solution; (3) The mixed solution from step (2) was subjected to ultrasonic treatment and heating treatment in sequence to obtain a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex.

[0010] In one embodiment of the present invention, in step (1), the mass concentration of lactoferrin in the lactoferrin solution is 8~15 g / L; the concentration of phlorizin solution is 5~15 mM.

[0011] In one embodiment of the present invention, in step (1), the volume ratio of phlorizin solution to lactoferrin solution is 1:(20~25).

[0012] In one embodiment of the present invention, in step (1), the dialysis is performed using a dialysis bag with a molecular weight cutoff of 8000~12000 Da, with deionized water as the dialysis medium, and dialysis is performed at 2~8℃ for 18~30 h.

[0013] In one embodiment of the present invention, in step (2), the mass concentration of carboxymethyl cellulose in the carboxymethyl cellulose solution is 0.5~2 g / L.

[0014] In one embodiment of the present invention, in step (2), the pH of the lactoferrin-phlorizin binary complex solution is 5.5-6.5, and the pH of the carboxymethyl cellulose solution is 5.5-6.5.

[0015] In one embodiment of the present invention, in step (2), the stirring temperature is 20~30℃, the stirring speed is 400~600 rpm, and the stirring time is 1~5 h.

[0016] In one embodiment of the present invention, in step (3), the ultrasonic treatment is: ultrasonic treatment at 35-45 kHz for 20-30 min at 20-30℃.

[0017] In one embodiment of the present invention, in step (3), the heating treatment is: stirring and heating at 60℃~80℃ for 5~20 min.

[0018] In one embodiment of the present invention, the lactoferrin-phlorizin-carboxymethyl cellulose ternary complex obtained in step (3) is dried.

[0019] In one embodiment of the present invention, the drying includes vacuum freeze drying and spray drying.

[0020] In one embodiment of the present invention, the freeze-drying is performed by pre-freezing at -80°C for 3-5 hours, followed by freeze-drying at a vacuum of ≤10 Pa and a cold trap temperature of ≤-40°C for 40-56 hours.

[0021] The second objective of this invention is to provide a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex prepared by the aforementioned preparation method.

[0022] A third objective of this invention is to provide the application of the lactoferrin-phlorizin-carboxymethyl cellulose ternary complex prepared by the method or the above-described method in the preparation of food, health products or pharmaceuticals.

[0023] In one embodiment of the present invention, the food includes dairy products and beverages.

[0024] The fourth objective of this invention is to provide a method for improving the thermal stability, ferrous ion chelating ability, and antioxidant activity of lactoferrin, wherein the method involves compounding lactoferrin with phlorizin and carboxymethyl cellulose.

[0025] In one embodiment of the present invention, the specific steps of the method are as follows: (1) A lactoferrin solution with a concentration of 8~15 g / L and a phlorizin solution with a concentration of 5~15 mM were mixed at a ratio of (20~25):1 and then dialyzed to obtain a lactoferrin-phlorizin binary complex solution. (2) Adjust the pH of the lactoferrin-phlorizin binary complex solution from step (1) and the carboxymethyl cellulose solution with a concentration of 0.5~2 g / L to 5.5~6.5 respectively, and then mix them at a volume ratio of (5~15):1 and stir for 1~5 h to obtain a mixed solution; (3) The mixed solution from step (2) was subjected to ultrasonic treatment and heating treatment in sequence to obtain a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex.

[0026] In one embodiment of the present invention, in step (3), the ultrasonic treatment is: ultrasonic treatment at 20~30℃ and 35~45 kHz for 20~30 min.

[0027] In one embodiment of the present invention, in step (3), the heating treatment is: stirring and heating at 60℃~80℃ for 5~20 min.

[0028] In one embodiment of the present invention, the lactoferrin-phlorizin-carboxymethyl cellulose ternary complex obtained in step (3) is dried.

[0029] In one embodiment of the present invention, the drying includes vacuum freeze drying and spray drying.

[0030] In one embodiment of the present invention, the freeze-drying is performed by pre-freezing at -80°C for 3-5 hours, followed by freeze-drying at a vacuum of ≤10 Pa and a cold trap temperature of ≤-40°C for 40-56 hours.

[0031] Beneficial effects The dense network structure in the ternary composite system constructed in this invention can effectively reduce the loss of active ingredients during heating and also enhances the ferrous ion chelating ability and antioxidant capacity to a certain extent. The LF-Phl-CMC ternary composite constructed in this invention is suitable for heat treatment in actual food processing while ensuring the functional activity of lactoferrin after processing. Furthermore, the entire preparation process does not use chemical cross-linking agents; the ternary composite is constructed solely through non-covalent interactions. The reaction conditions are mild, maximizing the preservation of the natural conformation and active sites of lactoferrin. The product has high safety, is suitable for large-scale industrial production, and has broad application prospects. 1. Dynamic light scattering (DLS) results show that the average particle size of LF-Phl-CMC is approximately 74.23 nm. Fourier transform infrared spectroscopy (FTIR) indicates that LF, Phl, and CMC form a stable composite network mainly through electrostatic interactions, hydrogen bonds, and hydrophobic interactions.

[0032] 2. No significant difference in turbidity was observed in LF-Phl-CMC between unheated samples and samples heated at 72℃ for 2 or 10 minutes (P>0.05), OD 600 <0.08). In contrast, after heating at 95°C for 10 min, the turbidity of pure LF and LF-Phl binary complex was 2 times and 1.5 times that of unheated complex, respectively, showing obvious turbidity and aggregated precipitation, while LF-Phl-CMC ternary complex remained clear and transparent.

[0033] 3. Fe of LF-Phl-CMC 2+ The chelating capacity was approximately 27%, higher than LF (24%), but slightly lower than LF-Phl (32%). The introduction of phlorizin enhanced Fe²⁺ chelation. + Chelating ability: Although the chelating ability decreases slightly after CMC participates in the formation of the ternary complex structure, it is still better than that of lactoferrin alone.

[0034] 4. LF-Phl-CMC initially exhibited slightly lower DPPH radical scavenging activity than LF-Phl, but its function retention was stronger after heat treatment. The DPPH radical scavenging activity of LF-Phl decreased from 45.64% in the untreated form to approximately 28.25%, while that of LF-Phl-CMC decreased from 30.40% to 26.69%. After heat treatment, the final antioxidant activity of LF-Phl-CMC showed no significant difference from that of LF-Phl. Attached Figure Description

[0035] Figure 1 The results of zeta potential measurements of the lactoferrin-phlorizin-carboxymethyl cellulose ternary complex under different volume ratios and pH values; Figure 2 The average particle size and corresponding PDI value of the lactoferrin-phlorizin-carboxymethyl cellulose ternary complex under different volume ratios and pH values ​​are shown in the figures. (A) Average particle size measurement results; (B) PDI value measurement results. Figure 3 The average particle size distribution of lactoferrin (LF), lactoferrin-phlorizin complex (LF-Phl), and lactoferrin-phlorizin-carboxymethyl cellulose complex (LF-Phl-CMC) is shown. Figure 4 Fourier transform infrared spectra of lactoferrin (LF), lactoferrin-phlorizin complex (LF-Phl), and lactoferrin-phlorizin-carboxymethyl cellulose complex (LF-Phl-CMC).

[0036] Figure 5 The appearance and turbidity changes of lactoferrin (LF), lactoferrin-phlorizin complex (LF-Phl) and lactoferrin-phlorizin-carboxymethyl cellulose complex (LF-Phl-CMC) before and after heat treatment; (A) Appearance (B) Turbidity; Figure 6 The effect of heat treatment on the intrinsic fluorescence spectra of lactoferrin (LF), lactoferrin-phlorizin complex (LF-Phl), and lactoferrin-phlorizin-carboxymethyl cellulose complex (LF-Phl-CMC). Figure 7 Scanning electron microscope images of lactoferrin (LF), lactoferrin-phlorizin complex (LF-Phl), and lactoferrin-phlorizin-carboxymethyl cellulose complex (LF-Phl-CMC) before and after heating. Figure 8 The ferrous ions (Fe2+) of the lactoferrin-phlorizin-carboxymethyl cellulose complex (LF-Phl-CMC) 2+ chelating ability; Figure 9 The DPPH free radical scavenging activity of the lactoferrin-phlorizin-carboxymethyl cellulose complex (LF-Phl-CMC) was evaluated. Figure 10 The thermal denaturation temperatures of different polysaccharides combined with phlorizin and lactoferrin; Figure 11 To evaluate the DPPH free radical scavenging activity of different polyphenols combined with lactoferrin. Detailed Implementation

[0037] The preferred embodiments of the present invention are described below. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention.

[0038] The test methods involved in the following embodiments: (1) Particle size and PDI determination: The particle size and particle size distribution of the composite were measured using a dynamic light scattering instrument at a scattering angle of 173° using disposable polystyrene cuvettes. The hydrodynamic diameter was determined based on the average particle size at light intensity.

[0039] (2) Zeta potential determination: The lactoferrin solution, lactoferrin-polyphenol, and lactoferrin-polyphenol-CMC ternary complex solution were adjusted to a concentration of 0.1% (w / v) with deionized water, respectively. The zeta potential was determined by measuring the electrophoretic mobility (UE) using a capillary electrophoresis device at room temperature using laser Doppler velocimetry.

[0040] (3) Turbidity determination: The lactoferrin solution, lactoferrin-polyphenol, and lactoferrin-polyphenol-CMC ternary complex solution were adjusted to a concentration of 0.1% (w / v) with deionized water. The dispersions were transferred to quartz cuvettes with an optical path of 1 cm, and the absorbance was measured at a wavelength of 660 nm using ultrapure water from the same batch as a reference. Each sample was measured in triplicate, and the arithmetic mean was taken. The result was then substituted into the linear regression equation of the standard working curve (constructed according to the methods of ISO 7027 and GB / T 5750.4—2023) to calculate the turbidity value of the sample.

[0041] (4) DPPH free radical scavenging rate determination: Lactoferrin solution and lactoferrin-polyphenol-CMC ternary complex solution were adjusted to a concentration of 0.1% (w / v) with deionized water. 150 μL of DPPH working solution (0.2 mM) and 50 μL of dispersion (25 μM) were added to a 96-well plate and incubated at 298 K in the dark for 30 min. The absorbance at 517 nm was measured using a microplate reader and recorded as A. The control group used an equal volume of methanol instead of DPPH working solution, and the absorbance of the sample itself at 517 nm was measured and recorded as A1. The blank group was a mixture of PBS buffer and DPPH working solution, and its absorbance at 517 nm was measured and recorded as A0. The DPPH free radical scavenging rate was calculated using the following formula: DPPH free radical scavenging rate (%) ; In the formula: A is the absorbance of the experimental group; A1 is the absorbance of the control group; A0 is the absorbance of the blank group.

[0042] (5) Fe 2+Chelation rate determination: FeCl2 solution and 5 mmol / L ferrozine solution were prepared separately using distilled water. 1 mL of the test solution was mixed thoroughly with 0.05 mL of FeCl2 solution and 0.2 mL of ferrozine solution, and allowed to stand at room temperature for 10 minutes. The absorbance value (A1) of the solution at 562 nm was measured. An equal volume of deionized water was used as the control group instead of the sample, and the absorbance value (A0) was measured. The chelating capacity of ferrous ions was calculated using the following formula: Ferrous ion chelating capacity (%) = ; In the formula: A0 is the absorbance of the control group; A1 is the absorbance of the sample group.

[0043] (6) Measurement of intrinsic fluorescence spectroscopy: Intrinsic fluorescence spectra were measured using a Lumina fluorescence spectrometer and a 10 mm quartz cuvette. The excitation wavelength was set to 295 nm, the emission wavelength range was 300 to 450 nm, and the scan rate was 200 nm / min. The intrinsic fluorescence spectra were measured at 25 °C, and the excitation and emission slit widths were both 5 nm.

[0044] Example 1 This embodiment provides a method for preparing a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex, the specific method of which is as follows: (1) Weigh lactoferrin (purity ≥95%) and dissolve it in phosphate buffer solution (pH 7.0, 10 mM) to obtain a 10 g / L lactoferrin working solution; (2) Weigh 43.64 mg of phlorizin (purity ≥98%) and dissolve it in 10 mL of anhydrous ethanol to prepare a 10 mM phlorizin stock solution, and store it at 4 °C protected from light. (3) Take 22 mL of the lactoferrin working solution obtained in step (1) and mix it with 1 mL of the phlorizin stock solution obtained in step (2). Place it in a dialysis bag with a molecular weight cutoff of 8000 kDa and use deionized water as the dialysis medium. Dialyze at 4℃ for 24 h to obtain a lactoferrin-phlorizin binary complex solution. (4) Weigh 100 mg of carboxymethyl cellulose (degree of substitution 0.7, viscosity 30 mPa·s) and dissolve it in 100 mL of phosphate buffer solution (pH 7.0, 10 mM). Adjust the pH to 6.0 to obtain a carboxymethyl cellulose solution with a mass concentration of 1 g / L. (5) Take 15 mL of the binary complex solution obtained in step (3), adjust the pH to 6.0, and then add it dropwise to 1 mL of the carboxymethyl cellulose solution obtained in step (4); wherein the volume ratio of the binary complex solution to the carboxymethyl cellulose solution is 15:1, and stir at 500 rpm for 2 h at room temperature; (6) Place the mixed solution obtained in step (5) in a 40 kHz ultrasonic processor and treat it at 27 ℃ for 25 min; then stir and heat it at 70 ℃ for 5 min. (7) The solution obtained in step (6) was dispensed into freeze-drying bottles and pre-frozen at -80 ℃ for 4 h. Then, it was freeze-dried at vacuum degree ≤10 Pa and cold trap temperature ≤-40 ℃ for 48 h to obtain lactoferrin-phlorizin-carboxymethyl cellulose ternary complex solid powder (LF-Phl-CMC). The mass ratio between the substances was 50:1:3.35.

[0045] Example 2: Referring to Example 1, the difference is that in steps (4) and (5), the pH value is adjusted to 5.0 and the volume ratio is 5:1, 10:1, and 15:1; the remaining steps are the same as in Example 1.

[0046] The results showed that the 15:1 group had the smallest particle size (75 nm), and the particle size gradually increased as the mass ratio decreased, with the 5:1 group having the largest particle size (92 nm), an increase of about 23%. The 15:1 and 10:1 groups were similar and better in terms of particle size and PDI, while the 5:1 group had a large particle size, poor dispersibility, and significantly insufficient system stability.

[0047] Example 3: Referring to Example 1, the difference is that in steps (4) and (5), the pH value is adjusted to 7.0 and the volume ratio is 5:1, 10:1, and 15:1; in step (6), the ultrasonic treatment time is 25 min; the remaining steps are the same as in Example 1.

[0048] The results showed that the 15:1 group had the smallest particle size (88 nm) and the lowest PDI (0.27), and performed best; the 10:1 and 5:1 groups had significantly larger particle sizes (nearly doubling), and the 5:1 group had extremely poor dispersibility (particle size of 140 nm; PDI of 0.74).

[0049] Example 4: Referring to Example 1, the difference is that in steps (4) and (5), the pH value is adjusted to 8.0 and the volume ratio is 5:1, 10:1, and 15:1; in step (6), the ultrasonic treatment time is 25 min; the remaining steps are the same as in Example 1.

[0050] The results showed that the 15:1 group had the smallest particle size (72 nm) and the lowest PDI (0.27), with obvious advantages; as the mass ratio decreased, both the particle size and PDI increased, and the 5:1 group performed the worst (particle size 128 nm; PDI 0.76).

[0051] Example 5: Referring to Example 1, the difference is that in steps (4) and (5), the pH value is adjusted to 9.0 and the volume ratio is 5:1, 10:1, and 15:1; in step (6), the ultrasonic treatment time is 25 min; the remaining steps are the same as in Example 1.

[0052] The results showed that the 10:1 ratio had the smallest particle size (82 nm), while the 15:1 and 5:1 ratios had larger particle sizes; however, the PDI of the 15:1 ratio (0.47) was better than that of the 10:1 ratio (0.5). The 10:1 ratio had the best particle size, while the 15:1 ratio had the best dispersibility.

[0053] Example 6: Referring to Example 1, the difference is that in step (5), the volume ratio is 5:1 or 10:1; in step (6), the ultrasonic treatment time is 25 min; the remaining steps are the same as in Example 1.

[0054] Comparative Example 1: Referring to Example 1, the difference is that only lactoferrin working solution was used, without the addition of phlorizin and carboxymethyl cellulose. The rest of the operation was the same as in Example 1, and LF was prepared.

[0055] Comparative Example 2: Referring to Example 1, the difference is that only the lactoferrin-phlorizin binary complex solution was used, without the addition of carboxymethyl cellulose. The rest of the operation was the same as in Example 1, and the binary complex LF-Phl was prepared.

[0056] Test example: The performance of LF-Phl-CMC, LF, and LF-Phl prepared in Example 1, Comparative Example 2, and Comparative Example 2 was tested as follows: 1. Dispersion DLS results showed that the average particle sizes of LF, LF-Phl, and LF-Phl-CMC were approximately 53.33, 68.43, and 74.23 nm, respectively, indicating that phlorizin was successfully loaded onto lactoferrin, and CMC was further coated on the surface of the composite particles. Figures 1-3 ).

[0057] FTIR results show that LF, Phl, and CMC mainly form a stable complex network through electrostatic interactions, hydrogen bonds, and hydrophobic interactions. Figure 4 ).

[0058] 2. Verification of heat treatment stability Take 10 mL of the emulsion obtained in Example 1 and place it in a sealed glass tube. Heat it in a 72°C water bath for 2 min or 10 min, followed by heating in a 95°C water bath for 10 min. After heating, immediately cool it to 4°C in an ice bath. Use the unheated sample as a control. At the same time, the heat treatment stability of LF and LF-Phl was determined using the same method.

[0059] The results are as follows Figures 5-7 As shown, the introduction of CMC significantly improved the thermal stability of the system. CMC can effectively inhibit the heat-induced aggregation and conformational unfolding of lactoferrin, thereby improving the thermal stability of the composite system. The LF-Phl-CMC ternary complex exhibited superior thermal stability. No significant difference in turbidity was observed between the unheated sample and the sample heated at 72 °C for 2 min or 10 min. P >0.05), all OD 600 The values ​​remained at a low level (OD). 600 <0.08). The turbidity of pure LF and the LF-Phl binary complex increased significantly upon heating. After heating at 95℃ for 10 min, the turbidity of LF and LF-Phl was 2 times and 1.5 times that of the unheated solution, respectively, with obvious turbidity and aggregated precipitation. The LF-Phl-CMC ternary complex, however, remained clear and transparent, with no significant change in turbidity. Intrinsic fluorescence spectroscopy results showed a significant red shift in the maximum emission wavelength of LF and LF-Phl after heating, indicating exposure of hydrophobic regions and conformational denaturation. In contrast, the maximum emission wavelength of LF-Phl-CMC did not shift significantly, indicating stable protein conformation.

[0060] Scanning electron microscopy results further confirmed that after heating, LF and LF-Phl exhibited severe particle aggregation, with significantly increased particle size and non-uniform structure; while LF-Phl-CMC, due to its more dense and continuous composite network, maintained a uniformly dispersed nanoparticle morphology and did not show obvious disordered aggregation.

[0061] 3. Ferrous ion chelating ability Fe 2+ Chelation results showed that the chelation capacity of LF-Phl-CMC was approximately 27%, slightly lower than that of LF-Phl (32%), but still higher than that of LF (24%), indicating that phlorizin can enhance Fe² to a certain extent. + Chelating ability. However, when CMC further participates in the formation of a ternary composite structure, the chelating ability shows a slight decrease ( Figure 8 ).

[0062] 4. Antioxidant activity Antioxidant activity results showed that LF-Phl-CMC initially had a slightly lower DPPH radical scavenging capacity than LF-Phl, but its function retention was stronger after heat treatment. The DPPH radical scavenging activity of LF-Phl decreased from 45.64% in untreated LF-Phl to approximately 28.25%, while that of LF-Phl-CMC decreased from 30.40% to 26.69%. It is evident that although LF-Phl has higher overall antioxidant activity, it suffers greater loss of active ingredients after heat treatment, and its final antioxidant activity is not significantly different from that of LF-Phl-CMC, indicating poor thermal stability. Figure 9 ).

[0063] The dense network structure in the ternary composite system can effectively reduce the loss of active ingredients during heating, allowing LF-Phl-CMC to retain high antioxidant activity after heat treatment, reducing the degradation loss of active substances during processing, and making it more suitable for heat treatment in actual food processing.

[0064] Comparative Example 3: Referring to Example 1, the difference is that the carboxymethyl cellulose in Example 1 is replaced with inulin (average degree of polymerization 25), dextran, carboxymethyl chitosan (degree of substitution 0.8), and pectin in equimolar carboxyl equivalents, while the other parameters remain unchanged.

[0065] from Figure 10 As can be seen from the comparison of the thermal denaturation temperatures of ternary complexes formed by different polysaccharides (carboxymethyl chitosan, inulin, CMC, dextran, and pectin) with LF-polyphenols, CMC showed the best effect (Td=75.5℃, an increase of 10℃), followed by carboxymethyl chitosan and pectin, while dextran showed the worst effect (Td=69.3℃, an increase of only 3.8℃). This indicates that different polysaccharide structures have different effects on the thermal stability of the complex, and CMC can better form a stable complex network with lactoferrin and phlorizin, thus having a greater advantage in improving the thermal stability of the system.

[0066] Comparative Example 4: Referring to Example 1, the difference is that phlorizin (PHL) in Example 1 is replaced with equimolar phenolic hydroxyl equivalents of ligustrazine (LGF), typhaein (TYP), polygalactoside (PDT), and rutin (RUT), while the other parameters remain unchanged.

[0067] from Figure 11 It can be seen that, compared with different polyphenols, the lactoferrin-phlorizin-CMC complex showed the most significant improvement in antioxidant activity. The LF-PHL group had the highest DPPH free radical scavenging rate, reaching approximately 54.5%, significantly higher than other groups. The LF-LGF and LF-TYP groups were next, with scavenging rates of approximately 31.8% and 32.0%, respectively. The LF and LF-PDT groups had scavenging rates of approximately 20.8% and 22.3%, respectively, which were at a relatively low level. Studies have shown that rutin contains 10 hydroxyl groups in its molecular structure, the most among polyphenols. Its DPPH free radical scavenging activity (IC50 of 0.057 mg / mL) is comparable to that of vitamin C and caffeic acid, and significantly higher than that of phlorizin (IC50 of 3.98 mg / mL). However, after being combined with lactoferrin, the free radical scavenging rate of rutin was actually lower than that of phlorizin.

[0068] Comparative Example 5: Referring to Example 1, the difference is that the ultrasonic treatment is omitted, while the other parameters remain unchanged.

[0069] The results showed that the embedding rate of the heat-only (H) treatment group was 75.41%, which was 15.3% lower than the embedding rate of the ultrasound + heat synergistic treatment (H+US) group in Example 1 (89.04%). This indicates that although heat treatment alone can promote protein conformational adjustment, it is prone to protein aggregation and has limited improvement on system homogenization, thus resulting in a relatively low embedding effect.

[0070] Comparative Example 6: Referring to Example 1, the difference is that the heating treatment is omitted, while the other parameters remain unchanged.

[0071] The results showed that the embedding rate of the ultrasound (US) treatment group was 82.84%, which was 6.96% lower than that of the ultrasound + heating synergistic treatment (H+US) group in Example 1. Ultrasound treatment alone can effectively improve dispersibility, but due to the lack of heat-induced protein conformational rearrangement, its promoting effect on the exposure of phlorizin binding sites and the densification of complex structure is relatively insufficient.

[0072] Although the present invention has been disclosed above with reference to preferred embodiments, it is not intended to limit the present invention. Anyone skilled in the art can make various modifications and alterations without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be determined by the claims.

Claims

1. A method for preparing a lactoferrin-phlorizin-carboxymethyl cellulose ternary complex, characterized in that, The method steps are as follows: (1) After mixing lactoferrin solution and phlorizin solution, a lactoferrin-phlorizin binary complex solution was prepared by dialysis; (2) The lactoferrin-phlorizin binary complex solution from step (1) is mixed with carboxymethyl cellulose solution at a volume ratio of 5:1 to 15:1 and stirred for 1 to 5 h to obtain a mixed solution; (3) The mixed solution in step (2) was subjected to ultrasonic treatment and heating treatment in sequence to obtain lactoferrin-phlorizin-carboxymethyl cellulose ternary complex; The ultrasonic treatment is as follows: ultrasonication at 35-45 kHz for 20-30 min at 20-30℃. The heat treatment is performed by stirring and heating at 60℃~80℃ for 5~20 minutes.

2. The preparation method according to claim 1, characterized in that, In step (1), the mass concentration of lactoferrin in the lactoferrin solution is 8~15 g / L; the concentration of phlorizin solution is 5~15 mM; and the volume ratio of phlorizin solution to lactoferrin solution is 1:(20~25).

3. The preparation method according to claim 1, characterized in that, In step (1), the dialysis is performed using a dialysis bag with a molecular weight cutoff of 8000~12000 Da, with deionized water as the dialysis medium, and dialysis is performed at 2~8℃ for 18~30 h.

4. The preparation method according to claim 1, characterized in that, In step (2), the mass concentration of carboxymethyl cellulose in the carboxymethyl cellulose solution is 0.5~2 g / L; the pH of the lactoferrin-phlorizin binary complex solution is 5.5~6.5, and the pH of the carboxymethyl cellulose solution is 5.5~6.

5.

5. The preparation method according to claim 1, characterized in that, In step (2), the stirring temperature is 20~30℃, the stirring speed is 400~600 rpm, and the stirring time is 1~5 h.

6. The preparation method according to claim 1, characterized in that, The lactoferrin-phlorizin-carboxymethyl cellulose ternary complex obtained in step (3) was dried.

7. The lactoferrin-phlorizin-carboxymethyl cellulose ternary complex prepared by any of the preparation methods described in claims 1 to 6.

8. The preparation method according to any one of claims 1 to 6 or the lactoferrin-phlorizin-carboxymethyl cellulose ternary complex according to claim 7 in the preparation of food, health products or pharmaceuticals.

9. A method for improving the thermal stability, ferrous ion chelating ability, and antioxidant activity of lactoferrin, characterized in that, The method involves compounding lactoferrin with phlorizin and carboxymethyl cellulose.

10. The method according to claim 9, characterized in that, The specific steps of the method are as follows: (1) A lactoferrin solution with a concentration of 8~15 g / L and a phlorizin solution with a concentration of 5~15 mM were mixed at a ratio of (20~25):1 and then dialyzed to obtain a lactoferrin-phlorizin binary complex solution. (2) Adjust the pH of the lactoferrin-phlorizin binary complex solution and the carboxymethyl cellulose solution with a concentration of 0.5~2 g / L in step (1) to 5.5~6.5 respectively, and then mix them at a volume ratio of (5~15):1 and stir for 1~5 h to obtain a mixed solution; (3) The mixed solution in step (2) was subjected to ultrasonic treatment and heating treatment in sequence to obtain lactoferrin-phlorizin-carboxymethyl cellulose ternary complex; In step (3), the ultrasonic treatment is: ultrasonic treatment at 35-45 kHz for 20-30 min at 20-30℃; In step (3), the heating treatment is: stirring and heating at 60℃~80℃ for 5~20 min.

Citation Information

Patent Citations

  • Preparation method of protein-polyphenol-polysaccharide covalent complex and application of protein-polyphenol-polysaccharide covalent complex

    CN108719999A

  • Ternary compound based on lactoferrin-pectin-phenolic acid and colorful functional beverage thereof

    CN118402591A

  • Preparation method of lactoferrin-polyphenol nanocomposite with intestinal immune function

    CN119453497A